Expanded Pneumococcal Vaccine Use

This is a U.S. news story, published by Yahoo, that relates primarily to CDC news.

U.S. news

For more U.S. news, you can click here:

more U.S. news

News about vaccine development

For more vaccine development news, you can click here:

more vaccine development news

Yahoo news

For more news from Yahoo, you can click here:

more news from Yahoo

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about

pneumococcal vaccines

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest vaccine news, vaccines news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

generation vaccine

Reuters

•

US CDC advisers recommend expanding pneumococcal vaccine to adults aged 50-64

Summary

Nutrition label

81% Informative

The CDC currently recommends all children younger than 5 and all adults 65 years or older get vaccinated.

Vaccines from Merck and Pfizer are currently available in the U.S. market.

Pneumococcal disease can cause infections in several body parts, including lung pneumonia, and spreads through direct contact with respiratory secretions.

VR Score

Informative language

Neutral language

Article tone

formal

Language

English

Language complexity

Offensive language

not offensive

Hate speech

not hateful